ALZFORUM

Second Trial of Diaphragm Pacing for ALS Shuts Down

A second clinical trial of a diaphragm pacer for people with ALS has shut down early, and another hangs in limbo, as doctors and patients wonder if the surgically implanted device—meant to improve ...
Medscape

FDA Grants Humanitarian Use Device Designation for Diaphragm Pacing System in ALS

October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic ...
Medscape

Diaphragm Pacing System May Ease Breathing in ALS Patients

April 19, 2005 — Implantation of a minimally invasive diaphragm pacing system (DPS) with therapeutic electrostimulation may help maintain diaphragm function and slow or arrest the rate of respiratory ...
Crain's Cleveland Business

FDA approval helps broaden access of Synapse Biomedical's diaphragm pacing system

Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on ...
Nature

Diaphragm pacing is associated with reduced survival in ALS patients with respiratory insufficiency

Respiratory failure is the principal cause of death in patients with amyotrophic lateral sclerosis (ALS), and noninvasive ventilation can prolong life by several months in these individuals.
Healio

FDA grants premarket approval to diaphragm pacing system

Please provide your email address to receive an email when new articles are posted on . Synapse Biomedical has received premarket approval from the FDA for its NeuRx Diaphragm Pacing System, which ...
WKYC3

FDA approves diaphragm pacing technology tested at University Hospitals to help patients come off ventilators

CLEVELAND — Medical technology that was created in Cleveland has been given emergency approval by the FDA to help patients wean off ventilators. Oberlin-based Synapse Biomedical, working with ...
FiercePharma

Muscular Dystrophy Association And The ALS Association Fund Clinical Trial Of Diaphragm Pacing System In People With ALS

ALS (also known as Lou Gehrig's disease) attacks the nerve cells that control muscles, ultimately resulting in paralysis of all voluntary muscles, including those used for breathing. Average life ...
BioWorld

Items Tagged with 'Transaeris diaphragm pacing system'

Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
Grand Forks Herald

FDA approves diaphragm-pacing device

The U.S. Food and Drug Administration recently announced that it approved the NeuRx DPS RA/4 Respiratory Stimulation System, an implantable electronic device that stimulates the diaphragm and allows ...
BioWorld

Synapse’s diaphragm pacing system nabs FDA breakthrough status

Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...